Tirzepatide as a GIP / GLP1 co-agonist for therapy

PK144883APending Publication Date: 2026-09-04ELI LILLY & CO

0 Cites 0 Cited by

Patent Information

Application Number: PK201900516
Authority / Receiving Office: PK · PK
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2019-07-22
Publication Date: 2026-09-04

Application Information

Patent Timeline

22 Jul 2019

Application

PK201900516

04 Sep 2026

Publication

PK144883A

Inventors: Axel HAUPT; Melissa Kay THOMAS

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention provides Tirzepatide as a GIP / GLP1 coagonist for increasing glycemic control,or a condition selected from atherosclerosis,chronic kidney disease,NAFLD,and NASH.Further provided is Tirzepatide administered using a dosing regimen for therapy.

Need to check novelty before this filing date? Find Prior Art